[HTML][HTML] ERS/ESICM/ESCMID/ALAT guidelines for the management of severe community-acquired pneumonia

I Martin-Loeches, A Torres, B Nagavci, S Aliberti… - Intensive care …, 2023 - Springer
Purpose Severe community-acquired pneumonia (sCAP) is associated with high morbidity
and mortality, and whilst European and non-European guidelines are available for …

[HTML][HTML] Infection control in long term care institutions for the elderly: A reflection document on the situation in Spain

E Bouza, JAG Navarro, S Alonso… - Revista Española de …, 2023 - ncbi.nlm.nih.gov
A progressively increasing percentage of the elderly live during the last years of their lives in
nursing homes. Although these institutions are intended to mimic life at home as much as …

A review of the value of point-of-care testing for community-acquired pneumonia

A Palomeque, C Cilloniz, A Soler-Comas… - Expert Review of …, 2024 - Taylor & Francis
Introduction Community-acquired pneumonia (CAP) is an infectious disease associated with
high mortality worldwide. Although Streptococcus pneumoniae remains the most frequent …

[HTML][HTML] Mortalidad tras el alta desde el servicio de urgencias hospitalario: análisis de 453.599 episodios

TM Orozco, JMR Rincón, B Espinosa… - … : Revista de la …, 2024 - dialnet.unirioja.es
Objetivos. Cuantificar y analizar la mortalidad de los pacientes dados de alta directamente
desde un servicio de urgencias hospitalario (SUH) y que fallecen dentro de los primeros 30 …

Estimating the risk of bacteraemia in hospitalised patients with pneumococcal pneumonia

L Serrano, LA Ruiz, S Pérez, PP España, A Gomez… - Journal of Infection, 2022 - Elsevier
Objective To construct a prediction model for bacteraemia in patients with pneumococcal
community-acquired pneumonia (P-CAP) based on variables easily obtained at hospital …

Treatment Failure and Clinical Stability in Severe Community-Acquired Pneumonia

R Méndez, P González-Jiménez… - … in Respiratory and …, 2024 - thieme-connect.com
Treatment failure and clinical stability are important outcomes in community-acquired
pneumonia (CAP). It is essential to know the causes and risk factors for treatment failure and …

[HTML][HTML] Impact of reducing the duration of antibiotic treatment on the long-term prognosis of community acquired pneumonia

A Uranga, A Artaraz, A Bilbao, JM Quintana… - BMC Pulmonary …, 2020 - Springer
Background The optimal duration of antibiotic treatment for community-acquired pneumonia
(CAP) is not well established. The aim of this study was to assess the impact of reducing the …

Comportamiento de variables clínicas y humorales al ingreso como predictores de fallecimiento en pacientes con neumonía adquirida en la comunidad. Estudio …

LAC Martínez, IG Morales… - International Journal of …, 2022 - revistas.uautonoma.cl
Community-acquired pneumonia is recognized as one of the main infectious health
problems worldwide. The objective was to determine the condition of predictors of death for …

[HTML][HTML] Cappric study—characterization of community-acquired pneumonia in spanish adults managed in primary care settings

J Molina, A González-Gamarra, L Ginel, ME Peláez… - Microorganisms, 2021 - mdpi.com
The real burden of community-acquired pneumonia (CAP) in non-hospitalized patients is
largely unknown. This is a 3-year prospective, observational study of ambulatory CAP in …

[HTML][HTML] Safety of fluoroquinolones

J Barberán, A de la Cuerda, MIT González… - Revista Española de …, 2024 - ncbi.nlm.nih.gov
Fluoroquinolones (FQs) are one of the most commonly prescribed classes of antibiotics.
Although they were initially well tolerated in randomized clinical trials, subsequent …